11.07.2015 Views

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Discussionlow threshold, we <strong>in</strong>crease the likelihood of also identify<strong>in</strong>g such changes that are presentonly <strong>in</strong> a m<strong>in</strong>or fraction of the sample.In a diag<strong>no</strong>stic perspective, all tumor-specific <strong>alterations</strong> are potentially useful for earlydetection, regardless of their impact on tumor aggressiveness. In this sense, carc<strong>in</strong>omasamples could also be scored as positive when weakly methylated. However, the currentscor<strong>in</strong>g thresholds provides very conservative results, <strong>and</strong> ensures that DNA methylation isneither over-estimated <strong>in</strong> carc<strong>in</strong>oma samples <strong>no</strong>t under-estimated <strong>in</strong> <strong>no</strong>rmal samples. Thisalso accounts for the result<strong>in</strong>g sensitivity <strong>and</strong> specificity measurements.MSP is a highly sensitive method as 1 methylated allele among 1000 alleles is detectable[141].Even though the MSP <strong>in</strong> itself is qualitative <strong>and</strong> the scor<strong>in</strong>g of the MSP is visual, the resultsare highly reproducible, which <strong>in</strong>dicates that the b<strong>and</strong> <strong>in</strong>tensities most likely de<strong>no</strong>te theamount of methylated alleles <strong>in</strong> the lesion. This is verified <strong>in</strong> paper II, where the MGMTgene has been analyzed <strong>in</strong> a bl<strong>in</strong>ded manner with both quantitative <strong>and</strong> qualitative MSP. Fullconcordance was achieved, underl<strong>in</strong><strong>in</strong>g the value of carefully designed assays, well optimizedreactions <strong>and</strong> thorough scor<strong>in</strong>g of the results.Bisulfite sequenc<strong>in</strong>gBisulfite sequenc<strong>in</strong>g reads out the methylation status of <strong>in</strong>dividual CpG sites <strong>in</strong> a givensequence <strong>and</strong> is considered to be the most comprehensive method for study<strong>in</strong>g methylationchanges. Primers are designed to exclude, or limit, the number of CpG sites <strong>in</strong> order toamplify both methylated <strong>and</strong> unmethylated DNA <strong>in</strong> a <strong>no</strong>n-biased manner. A 5-methylcytos<strong>in</strong>ewill be read as a cytos<strong>in</strong>e <strong>in</strong> the f<strong>in</strong>al sequence, whereas an unmethylated cytos<strong>in</strong>ewill be read as a thym<strong>in</strong>e[139].Bisulfite sequenc<strong>in</strong>g can be performed either directly on the PCR product or by sequenc<strong>in</strong>gclones conta<strong>in</strong><strong>in</strong>g the PCR product. The direct sequenc<strong>in</strong>g is fast <strong>and</strong> simple <strong>and</strong> will providean average methylation frequency for each of the CpG sites <strong>in</strong> the entire target sequence. Incontrast, the clon<strong>in</strong>g approach is more work dem<strong>and</strong><strong>in</strong>g, but will provide exact methylationstatus for each of the CpG sites <strong>in</strong> the <strong>in</strong>dividual clones[144]. The choice of approach46

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!